PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials
August 17, 2022 – The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of a joint development agreement (JDA) supporting the progression of two investigational tuberculosis (TB) combination treatment regimens into phase 2 clinical development. The collaboration will evaluate whether the novel regimens, which combine registered products and new chemical entities (NCEs), can effectively treat all forms of active pulmonary TB using substantially shorter treatment durations than existing drug regimens, with the goal of identifying a regimen suitable for phase 3 develo...
Source: Johnson and Johnson - August 17, 2022 Category: Pharmaceuticals Source Type: news
Africa: Pharmaceutical Company GSK Awarded U.S.$170 Million Contract to Produce Malaria Vaccine
[UN News] The pharmaceutical company GSK has been awarded a contract to produce the world's first malaria vaccine so that millions more children will be protected against the killer disease, the UN Children's Fund (UNICEF) announced on Tuesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 17, 2022 Category: African Health Source Type: news
Africa: Millions More Children to Benefit From Malaria Vaccine As UNICEF Secures Supply
[Unicef] New York/Copenhagen -- With malaria one of the biggest killers of children under 5, the world's first vaccine against a parasite is a major breakthrough for child health (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 17, 2022 Category: African Health Source Type: news
Millions more children to benefit from world ’s first malaria vaccine: UNICEF
The pharmaceutical company GSK has been awarded a contract to produce the world’s first malaria vaccine so that millions more children will be protected against the killer disease, the UN Children’s Fund (UNICEF) announced on Tuesday.
(Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - August 16, 2022 Category: International Medicine & Public Health Source Type: news
Illumina Helped the World Fight COVID-19. Now, CEO Francis deSouza Has Monkeypox in His Sights
As chief executive of San Diego-based genomic sequencing company Illumina, Francis deSouza feels well-placed to witness the world’s next great scientific transformation.
“I really believe that just like the 20th century was the era of the bit and the digital revolution, the 21st century is likely to be remembered as the era of the genome,” he says. “We’re seeing that play out in terms of genomic-based screening and diagnostics emerging, like Illumina’s offerings, but we’re also seeing the emergence of genomic-based medicine.”
DeSouza’s excitement is understandable. Well...
Source: TIME: Health - August 14, 2022 Category: Consumer Health News Authors: John Simons Tags: Uncategorized biztech2030 The Leadership Brief Source Type: news
54gene ’ s CEO Abasi Ene-Obong Wants to Fix the Racial Imbalance in Health Data
Born and raised in the Nigerian port city of Calabar, Abasi Ene-Obong remembers the exact moment that changed his life’s direction. Sitting in an introductory genetics class at medical school, in 2003, he heard the professor say that African genetic samples comprised less than 3% of health data bases in the world, creating a stunning vacuum in its ability to detect diseases and develop effective treatments for hundreds of millions of people.
Ene-Obong ditched his plan to become a doctor, and instead left for London, and later Los Angeles, to study genetics, finally earning a Master’s degree in business focusing...
Source: TIME: Health - August 7, 2022 Category: Consumer Health News Authors: Vivienne Walt Tags: Uncategorized biztech2030 Innovation Leadership The Leadership Brief TIME 2030 Source Type: news
Google ’s AI Lab, DeepMind, Offers ‘Gift to Humanity’ with Protein Structure Solution
Matt Higgins and his team of researchers at the University of Oxford had a problem.
For years, they had been studying the parasite that spreads malaria, a disease that still kills hundreds of thousands of people every year. They had identified an important protein on the surface of the parasite as a focal point for a potential future vaccine. They knew its underlying chemical code. But the protein’s all-important 3D structure was eluding them. That shape was the key to developing the right vaccine to slide in and block the parasite from infecting human cells.
[time-brightcove not-tgx=”true”]
The team&rsqu...
Source: TIME: Science - July 28, 2022 Category: Science Authors: Billy Perrigo Tags: Uncategorized Artificial Intelligence biztech2030 Source Type: news
Africa: Historic Funding to Expand Roll-Out of First-Ever Malaria Vaccine
[WHO-AFRO] Brazzaville -- The World Health Organization (WHO) welcomes the launch by Gavi, the Vaccine Alliance, of the landmark opportunity for countries to apply for funding to introduce, or further roll-out, the RTS,S/AS01 (RTS,S) malaria vaccine. This international support of nearly US$ 160 million from 2022-2025 will facilitate increased vaccine access to children at high risk of illness and death from malaria, starting with Ghana, Kenya and Malawi, the three African countries that began pilot introduction of the vaccine in 20 (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 22, 2022 Category: Infectious Diseases Source Type: news
Africa: Africa Prepares Rollout of World's First Malaria Vaccine
[VOA] Geneva -- Preparations are underway for the mass rollout of the world's first malaria vaccine to protect millions of children in Africa. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 22, 2022 Category: Infectious Diseases Source Type: news
Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Investor Update - July 18, 2022 Category: Pharmaceuticals Source Type: news
Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Media News - July 18, 2022 Category: Pharmaceuticals Source Type: news
Rwanda Focuses on Health Workers to Strengthen COVID-Related Services in 20 Districts
July 08, 2022Health workers in 20 districts throughout Rwanda are making higher-quality health services related to COVID-19 available to more people in their communities, thanks to training through IntraHealth’s USAID-fundedIngobyi project. Together with the Rwanda Ministry of Health, we are improving the quality and accessibility of services related to family planning, maternal and newborn health, as well as malaria prevention and treatment.“When COVID-19 began to spread in 2020, we had to pivot our preexisting plans and implementation strategies to make sure health workers had the right supplies and training ...
Source: IntraHealth International - July 8, 2022 Category: International Medicine & Public Health Authors: kseaton Tags: Rwanda Ingobyi Family Planning & Reproductive Health Infectious Diseases COVID-19 Malaria Maternal, Newborn, Child Health Health workforce development Global health security Systems Health Workers Source Type: news
‘You get goosebumps from the data’: hopes rise for new malaria vaccine
The disease is a leading killer of under fives across Africa. But trials for a new vaccine suggest an end to the death toll could be in sightWhen Annah Kadhenghi had her first child last year, she named him Brighton Ushindi Baraka:baraka meaning “blessing” in Swahili,ushindi meaning victory. Last month, at the age of seven months, Brighton fought his first battle against an enemy that plagues millions of the world ’s poorest: malaria.“His temperature was very high; he was vomiting. I took him to the hospital,” says Kadhenghi, a schoolteacher in Kilifi, eastern Kenya. Brighton defeated the mosquito-borne disease, ...
Source: Guardian Unlimited Science - June 27, 2022 Category: Science Authors: Lizzy Davies in Kilifi. Photography by Luis Tato for the Guardian Tags: Malaria Global development Kenya Africa World news Vaccines and immunisation Infectious diseases Health Medical research Source Type: news
GSK announces £1 billion R & D investment over ten years to get ahead of infectious diseases in lower-income countries
GSK plc (LSE/NYSE: GSK) announced an investment of £1bn over ten years to accelerate research and development (R&D) dedicated to infectious diseases that disproportionately impact lower-income countries.
This research will focus on new and disruptive vaccines and medicines to prevent and treat malaria, tuberculosis, HIV (through ViiV Healthcare), neglected tropical diseases (NTDs), and anti-microbial resistance (AMR), (Source: World Pharma News)
Source: World Pharma News - June 23, 2022 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news
Stronger Healthcare Systems Critical for Africa ’s Socioeconomic Transformation
As Africa rebuilds following the pandemic, investment in the fight against malaria and NTDs will make healthcare systems more resilient and support longer-term pandemic preparedness. Credit: UNDP Kenya/James OchweriBy Claude Mambo MuvunyiKIGALI, Jun 22 2022 (IPS) Since the outbreak of the COVID-19 pandemic, healthcare systems globally have battled to deal with the repercussions unleashed by the disease. From the outset, Africa was considered particularly vulnerable due to several factors: limited healthcare provision in some areas, high prevalence of HIV and TB in a number of countries, and limited fiscal room to respond t...
Source: IPS Inter Press Service - Health - June 22, 2022 Category: International Medicine & Public Health Authors: Claude Mambo Muvunyi Tags: Africa Headlines Health Poverty & SDGs TerraViva United Nations Source Type: news
